MiniMed (MMED) Net Margin (2025 - 2026)
MiniMed (MMED) posted Net Margin of 22.1% for Q2 2026, down 57.31% quarter-over-quarter from 14.05% in Q1 2026, and up 124.0% YoY from 9.87% in Q2 2025.
Powered by 
Analysis
MiniMed (MMED) Net Margin (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Net Margin data on file, last reported at 22.1% in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 124.0% year-over-year to 22.1%; the trailing twelve-month figure through Jul 2026 stood at 9.77% (changed N/A YoY), and the FY2026 full-year result was 10.22%, down 289.0% from the prior year.
- Net Margin was 22.1% for Q2 2026 at MiniMed, down from 14.05% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1.02% in Q1 2025 to a low of 23.34% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 13.47% |
| 10 | MiniMed | 6.55 Bn | 6.34 Bn | 465.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 24, 2026 | -22.10% |
| Jan 23, 2026 | -14.05% |
| Apr 25, 2025 | -23.34% |
| Jan 24, 2025 | -1.02% |